Richard Justus Siebert, MD | |
700 N Westmoreland Rd, Lake Forest, IL 60045-1679 | |
(847) 234-8808 | |
Not Available |
Full Name | Richard Justus Siebert |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 57 Years |
Location | 700 N Westmoreland Rd, Lake Forest, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205985157 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hrs Home Health | Lombard, IL | Home health agency |
Northwestern Lake Forest Hospital | Lake forest, IL | Hospital |
Northwestern Memorial Hospital | Chicago, IL | Hospital |
Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
Entity Name | Richard J Siebert, M.d.,s,c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003022088 PECOS PAC ID: 0941395933 Enrollment ID: O20071005000357 |
News Archive
A study involving older adults with pre-existing major depressive disorder living in Los Angeles, New York, Pittsburgh, and St Louis found no increase in depression and anxiety during the COVID-19 pandemic.
The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.
Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Richard Justus Siebert, MD 700 N Westmoreland Rd, Lake Forest, IL 60045-1679 Ph: () - | Richard Justus Siebert, MD 700 N Westmoreland Rd, Lake Forest, IL 60045-1679 Ph: (847) 234-8808 |
News Archive
A study involving older adults with pre-existing major depressive disorder living in Los Angeles, New York, Pittsburgh, and St Louis found no increase in depression and anxiety during the COVID-19 pandemic.
The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.
Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
› Verified 2 days ago
Dr. Joy Williams, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 Fax: 847-535-7203 | |
Dr. Jason T Garti, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Westmoreland Rd, Suite 100, Lake Forest, IL 60045 Phone: 847-234-8866 Fax: 824-234-4682 | |
Dr. Vikram Kanakayya Devisetty, M.D., M.B.A., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 | |
Mariam Anis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Westmoreland Rd # Level1, Lake Forest, IL 60045 Phone: 847-535-7647 Fax: 847-535-7151 | |
Jennifer M Nguyen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 | |
Andrew Min Jun Choi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 | |
Sam F Hull, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 951 Country Pl, Lake Forest, IL 60045 Phone: 847-295-5729 Fax: 847-295-5700 |